PRAX News and Press, Praxis Precision Medicines Inc. From 01/06/26

BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalan...

2026-01-06 16:09:50 ET More on Praxis Precision Medicines Praxis: Priced For Perfection Heading Into 2026 Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 Praxis: Moving To Strong Buy Based On Ulixacaltamide Success In Treating ET ...

BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalan...

2026-01-02 06:52:42 ET The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the ad...

2025-12-31 08:15:40 ET Introduction Stock of Praxis Precision Medicines ( PRAX ) has continued north following Phase 3 data for its essential tremor, or ET, drug candidate, ulixacaltamide.... Read the full article on Seeking Alpha For further details see: Praxis:...

2025-12-30 10:15:03 ET Citigroup analyst issues CONVICTION BUY recommendation for PRAX on December 30, 2025 01:22PM ET. The previous analyst recommendation was Conviction Buy. PRAX was trading at $294.29 at issue of the analyst recommendation. The overall analyst consens...

A look at the top 10 most actives in the United States Republic Power Group Ltd (RPGL) rose 159.6% to $0.6834 on volume of 526,371,087 shares Mereo BioPharma Group plc (MREO) fell 87.6% to $0.2854 on volume of 241,447,142 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.0% t...

2025-12-29 19:39:47 ET Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company received a Breakthrough Therapy Designation (BTD) for its experimental tremor treatment. By the close of trading, Praxis' stock pric...

A look at the top 10 most actives in the United States Republic Power Group Ltd (RPGL) rose 161.4% to $0.6882 on volume of 501,922,381 shares Mereo BioPharma Group plc (MREO) fell 87.6% to $0.2855 on volume of 215,784,569 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.2% t...

2025-12-29 09:29:05 ET More on Praxis Precision Medicines Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 Praxis: Moving To Strong Buy Based On Ulixacaltamide Success In Treating ET Praxis Precision Medicines, Inc. (PRAX) Discusses ...